• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INVIVO, A DIVISION OF PHILIPS MEDICAL SYSTEMS QUADTRODE MRI ECG PAD,25/BOX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INVIVO, A DIVISION OF PHILIPS MEDICAL SYSTEMS QUADTRODE MRI ECG PAD,25/BOX Back to Search Results
Model Number 989803179031
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Burn(s) (1757); Hypersensitivity/Allergic reaction (1907)
Event Date 02/11/2022
Event Type  Injury  
Manufacturer Narrative
A follow-up report will be submitted upon completion of the investigation.
 
Event Description
It was reported that the customer had a patient who had a sedated mri of his brain on friday, the 11th of february.This was a pretty quick scan and they used the last of the invivo quad ekg pads.The parent of the patient called to report the patient has what looks like burns on their chest.
 
Event Description
It was reported the patient was experiencing migraines.The patient had a sedated mri of his brain on friday, the 11th of february.This was a pretty quick scan and they used the last of the invivo quad ekg pads.The parent of the patient called to report the patient has what looks like burns on their chest.The patient saw their pediatrician who diagnosed as an allergic reaction.The patient was treated with motrin and was prescribed a cream.
 
Manufacturer Narrative
The product associated with the reported event was disposed of, therefore no evaluation/analysis could be performed.As evaluation/analysis was unable to be performed, the cause of the event could not be determined.The customer indicated to the philips complaint investigator that bjc did not prepare the patient¿s skin and when the patient arrived bjc would place the patient under sedation with propofol, the pad would be placed directly on the patient¿s chest and the leads would be connected.Bjc confirmed that the patient underwent a safety screening with the family before the scheduled procedure where the staff of bjc answered any mri specific questions that the patient¿s family may have had.A nurse practitioner and or an anesthesiologist at bjc then performed a safety screening to discuss the anesthesia risks involved with the procedure with the family.Finally, the surgery staff at bjc evaluated the patient for any known allergies, including any allergies to adhesives, foods, drugs, etc.It was reported the patient had no known allergies.Bjc confirmed that the mri procedure was a quick scan and lasted fifty minutes.Following the scheduled mri procedure, the parent of the patient contacted bjc the same day and stated that the patient had reacted and thought that the patient had experienced a burn.An image was forwarded to bjc by the patient¿s parents to evaluate the alleged site reaction phenomenon.Bjc suspected that the alleged burn appeared to look more like a site reaction to the pad adhesive.The mother of the patient was advised to treat the patient with motrin until the patient could present to a pediatrician.The patient¿s mother later contacted bjc and reported that after seeing a pediatrician, the patient was diagnosed with having an allergic reaction and a cream was prescribed to treat the patient.Bjc did indicate to the philips complaint investigator that the philips pads that were being used in this procedure were originally provided to bjc as samples and that the staff of bjc preferred to use them as they were more manageable.The customer confirmed that they had since run out of the philips pads and had switched to cardinal brand pads.A letter was sent to bjc with the results of the investigation, which included the contents of the pad adhesive and the testing standard to which these devices are submitted.Philips 989803179031, quadtrode mri ecg pad, 25/box are manufactured to pass iso 10993-1 and iso 10993-5 biocompatibility testing and iso 10993-10 testing for skin irritation and sensitization.Furthermore, bjc requested information related to the adhesives used in the philips 989803179031, quadtrode pads.A philips product industrialization engineer (pie) confirmed that the complaint device product adhesive was formulated for sustained contact with the human skin and had been tested for hypoallergenic properties by private bio-medical laboratories.The philips quadtrode pads consist of a cross linked 1.6mm polyethylene foam coated on one side with mp597, which is an acrylic based, hypoallergenic pressure sensitive adhesive which is protected by an 80gr calendered paper release liner.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUADTRODE MRI ECG PAD,25/BOX
Type of Device
QUADTRODE MRI ECG PAD,25/BOX
Manufacturer (Section D)
INVIVO, A DIVISION OF PHILIPS MEDICAL SYSTEMS
12151 research parkway
orlando FL 32826
Manufacturer (Section G)
INVIVO, A DIVISION OF PHILIPS MEDICAL SYSTEMS
12151 research parkway
orlando FL 32826
Manufacturer Contact
tara mackinnon
222 jacobs st
cambridge, MA 02141
6172455900
MDR Report Key13667377
MDR Text Key286580492
Report Number1051786-2022-00015
Device Sequence Number1
Product Code DPS
UDI-Device Identifier20884838029525
UDI-Public20884838029525
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K955045
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number989803179031
Device Catalogue Number989803179031
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/14/2022
Initial Date FDA Received03/04/2022
Supplement Dates Manufacturer Received03/28/2022
Supplement Dates FDA Received04/08/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age13 YR
Patient SexMale
Patient Weight58 KG
-
-